Li, Hongbo
Yang, Zihan
Huang, Jingbo
Lin, Lele
Shi, Dike
Chu, Yiming
Wu, Dan
Cai, Yanna
Li, Baozhong
Lu, Junyang
Guo, Qingqu
Funding for this research was provided by:
Chinese Academy of Medical Sciences (2023-I2M-C&T-B-026)
Article History
Received: 18 December 2024
Accepted: 27 March 2025
First Online: 7 April 2025
Declarations
:
: The authors declare no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Anyang Tumor Hospital (protocol code 2023WZ01K01). The animal study protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (protocol code AIRB-2023–0513).
: Informed consent was obtained from all subjects involved in the study. The authors confirm that all experiments were performed in accordance with relevant guidelines and regulations. The authors also confirm that this study has been reported in accordance with the ARRIVE guidelines.
: All authors have read and agreed to the published version of the manuscript.